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The FHIT Gene, Spanning the Chromosome 3p14.2
Fragile Site and Renal Carcinoma±Associated t(3;8)
Breakpoint, Is Abnormal in Digestive Tract Cancers
Masataka Ohta,* Hiroshi Inoue,*² The t(3;8) translocation breakpoint was cloned, and a
3 kb transcript of a candidate tumor suppressor geneMaria Grazia Cotticelli,*² Kumar Kastury,*²
was detected using a probe from near the breakpointRaffaele Baffa,*² Juan Palazzo,*
(Boldog et al., 1993); further details concerning this tran-Zurab Siprashvili,* Masaki Mori,³
script have not been reported. Cytogenetic studies inPeter McCue,* Teresa Druck,*
several of the familial tumors demonstrated that theCarlo M. Croce,* and Kay Huebner*
tumors had lost the derivative 8 chromosome carrying*Kimmel Cancer Center
the translocated 3p14-pter region; consequently, theJefferson Medical College
tumors were homozygous for all loci telomeric to thePhiladelphia, Pennsylvania
3p14.2 break (Li et al., 1993), suggestingthat theputative³Department of Surgery
suppressor gene should be telomeric to the 3p14.2Medical Institute of Bioregulation
break. It has also been suggested that there may notKyushu University
be a suppressor gene at 3p14.2, that in fact the t(3;8)Beppu 874
translocation was a mechanism for losing the von Hip-Japan
pel±Lindau gene, a tumor suppressor gene at 3p25
(Gnarra et al., 1994).
Another cytogenetic landmark in chromosome regionSummary
3p14.2 is the most common of the constitutive aphidi-
colin inducible fragile sites, FRA3B, which is cytogeneti-A 200±300 kb region of chromosome 3p14.2, including
cally indistinguishable from the t(3;8) translocationthe fragile site locus FRA3B, is homozygously deleted
(Glover et al., 1988). Fragile sites are regions of thein multiple tumor-derived cell lines. Exon amplification
human genome that reveal cytogenetically detectablefrom cosmids covering this deleted region allowed
gaps when exposed to specific reagents or culture con-identification of the human FHIT gene, a member of
ditions (for review, see Sutherland, 1991); several folatethehistidine triad gene family, whichencodes aprotein
sensitive, heritable, X-linked, and autosomal fragile siteswith 69% similarity to an S. pombe enzyme, diadenos-
have been localized to unstable CCG or CGG repeatsine 59, 5999 P1, P4-tetraphosphate asymmetrical hy-
(Yu et al., 1991; Kremer et al., 1991; Verkerk et al., 1991;drolase. The FHIT locus is composed of ten exons
Fu et al., 1991), and one of these, theFRA11B at 11q23.3,distributed over at least 500 kb, with three 59 untrans-
is associated with Jacobsen (11q-) syndrome, showing alated exons centromeric to the renal carcinoma±
direct link between a fragile site and in vivochromosomeassociated 3p14.2 breakpoint, the remaining exons
breakage (Jones et al., 1994). Because the induced frag-telomeric to this translocation breakpoint, and exon 5
ile sites resemble gaps or breaks in chromosomes, itwithin the homozygously deleted fragile region. Aber-
has frequently been speculated that fragile sites couldrant transcripts of the FHIT locus were found in z50%
be sites of chromosomal rearrangement in cancer (Yunisof esophageal, stomach, and colon carcinomas.
and Soreng, 1984), perhaps by increasing the incidence
of chromosome deletion during tumorigenesis.Introduction
The FRA3B region has been delineated by studies of
several groups using rodent±human hybrids; hybrid
In 1979, an Italian-American family was observed to be
cells retaining human chromosome 3 or 3 and X on a
transmitting a constitutional reciprocal t(3;8)(p14.2;q24)
hamster background were treated with aphidicolin or
chromosome translocation (Cohen et al., 1979; Wang 6-thioguanine (to select hybrids that had lost the X chro-
and Perkins, 1984), which segregated in the family with
mosome), and subclones were selected. Subclones re-
early onset, bilateral, and multifocal clear cell renal carci-
taining portions of chromosome 3 with apparent breaks
noma (RCC). It was suggested that the translocation
in region 3p14-p21 were characterized for loss or reten-
affects expression of a tumor suppressor gene (Cohen tion of specific 3p markers to determine the position of
et al., 1979), and several investigators have sought can- 3p14±21 breaks (LaForgia et al., 1991, 1993; Paradee et
didate suppressor genes. We had suggested the pro- al., 1995). Markers derived from yeast artificial chromo-
tein-tyrosine phosphatase g gene (PTPRG) as a candi- some (YAC) clones covering the t(3;8) break and sur-
date tumor suppressor gene (LaForgia et al., 1991) and rounding regions were used to demonstrate that the
showed that the 59 end of the PTPRG gene maps near 3p14.2 breaks representing the FRA3B were within a
but centromeric to the 3p14.2 break (Kastury et al., single YAC, 850A6, which thus covered the FRA3B, the
1996b) and that the majority of clear cell RCCs exhibit t(3;8) break, and the 59 end of the PTPRG gene (Paradee
loss of heterozygosity of a 0.5 Mb region flanking the et al., 1995; Kastury et al., 1996b). Using a 3p-linked
translocation (Lubinski et al., 1994; Druck et al., 1995), probe isolated by representational difference analysis
although we did not observe aberrations in the re- (RDA) (Lisitsyn et al., 1995),which detected homozygous
maining PTPRG gene. The 3p14.2 region is also included deletions in colon cancer-derived cell lines, we have
in deletions in numerous other tumor types, including recently further mapped this RDA probe to 3p14.2 within
nasopharyngeal carcinomas (Lo et al., 1994). the region defined as the FRA3B and have defined the
homozygous deletions in a range of types of cancer±
derived cell lines (Kastury et al., 1996a). We have now²These authors contributed equally to this work.
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Figure 1. Organization of the FHIT Gene Rel-
ative to the 3p14.2 FRA3B and Translocation
Sites
(A) A scheme of the normal 3p14.2 region is
shown with the chromosomal region (not to
scale) represented by the top line, with posi-
tions of STS markers (position of D3S1234
relative to the gene is not known), the FRA3B
represented by the hybrid cl3 break, and the
t(3;8) translocation break point shown. The
dashed portion represents the region in-
volved in the homozygous deletions in tumor
cell lines. Three of the YAC clones used in
developing the above markers, map,and cos-
mid contig are shown with the cosmid contig
below and the distribution of exons in the
FHIT transcript shown below the contig.
Closed and stippled boxes represent coding
and noncoding exons, respectively, E1±E10;
asterisks indicate exons with start and stop
codons.
(B) Organization of types of aberrant tran-
scripts from tumor cell lines are illustrated,
with zigzag regions representing insertions of new sequence, usually repetitive, into the aberrant transcripts. With CCL235 RNA as template,
apparently normal and aberrant RT±PCR products were amplified, with the aberrant product resulting from splicing of exon 4 to exon 8 with
a repetitive insert of 140 bp (contributing an in-frame Methione codon) between E4 and E8. RT±PCR amplification of RNA from HeLa cells
revealed normal and aberrant-sized products, the smallest product resulting from splicing of exon 4 to exon 9. RT±PCR amplification of RNA
from KatoIII, a gastric carcinoma-derived cell line with discontinuous deletions leaving all FHIT exons intact, resulted in an aberrant-sized
product that is missing exons 4 through 7, with an 86 bp repeat, inserted downstream of exon 3, contributing an in-frame Methionine codon.
Amplification of the RT product from HT29, a colon carcinoma±derived cell line with a large deletion that included exon 5, gave only an
aberrant-sized product resulting from splicing of exon 3 to exon 7. Numerous other tumor-derived cell lines from lung carcinoma (1 of 3
tested), osteosarcoma (1 of 2), NPC (3 of 3), ovarian carcinoma (2 of 2), and hematopoietic (4 of 5) tumors, exhibited aberrant FHIT transcription
products (data not shown).
(C) Amplification of specific exons from YAC, hybrid, and tumor DNA templates shows that exon 3 (amplified using primers iex3F, 59-
AGGGTGATACTAGCTGCTTT-39, iex3R, 59-TGACTTTAGCCAGTGGCA) is present in YAC 850A6 (E3, lane 1), absent in hamster and mouse
DNA (E3, lanes 2 and 3), present in human and hybrid cl3 DNA (E3, lanes 4 and 5), and absent in hybrid clone 5L.8 DNA (E3, lane 6). Since
hybrid cl3 retains chromosome 3 region 3p14.2 to 3qter with the break in the fragile region as shown above (see Figure 1A) and is positive
for E3, while hybrid 5L.8 retains 3p14.2 to 3pter, the portion of 3 translocated to chromosome 8 in the t(3;8) family, and is negative for E3,
exon 3 must be centromeric to the t(3;8) break. Similarly, the E4 panel with identical DNA templates, 850A6 (lane 1), hamster, and mouse
DNA (lanes 2 and 3), human (lane 4), cl3 (lane 5), and 5L.8 (lane 6) DNAs, from which exon 4 was amplified (using primers iex4F, 59-
TTGTACCTAGAGCCATCTGG-39; iex4R, 59-GGATACTCACAGCAGGTCAA-39), shows that exon 4 is present in both hybrids cl3 and 5L.8,
indicating that it must be telomeric to the t(3;8). Exon 4 is not present in the 648D4 cosmid contig (data not shown) and so must be
between this cosmid contig and the t(3;8) break. Other exons and markers were similarly mapped. Exon 5 (amplified using primers X2, 59-
TGAGGACATGTCGTTCAGATTT-39; G1, 59-CTGGTGTCTCCGAAGTGGGAGGG-39), was absent in tumor cell lines Hela and HT29 (E5, lanes 1
and 2) and present in tumor cell lines LS180, KatoIII, and YAC 850A6 (E5, lanes 4±6).
developed a cosmid contig covering the homozygous et al., 1993; Druck et al., 1995). Six cosmids were assem-
bled into a contig that covered the homozygously de-deletions and have characterized a gene that is a target
leted region.of deletions in uncultured tumors of esophagus, stom-
To define more precisely the homozygously deletedach, colon, and probably other organs.
region, which we will refer to as the fragile region, 42
STS markers, spanning the chromosomal region from
Results the PTPRG locus to D3S1234, derived from cosmid
walking and exon trapping, were tested by PCR amplifi-
The Cosmid Contig cation for presence in eleven cancer-derived cell lines
From the 648D4 cosmid library, clones were selected that had been tested previously with a subset of markers
initially using the BE758-6, A6URA, A3, and 1300E3 (Lisitsyn et al., 1995; Kastury et al., 1996a).
probes, which were distributed across the homozy- Colon carcinoma±derived LoVo, HT29, SW480, and
gously deleted region as shown in Figure 1A. Cosmid gastric carcinoma±derived AGS cell lines showed similar
end clones were then isolated and used for the next large deletions, as depicted by the dotted portion of the
round of cosmid screening. The cosmid map was as- top line in Figure 1A. Colon carcinoma±derived LS180
sembled by polymerase chain reaction (PCR) amplifica- and breast carcinoma±derived MDA±MB436 cells exhib-
tion of the starting sequence-tagged sites (STSs), and ited discontinuous deletions covering this same region,
new ones developed from cosmid ends, using cosmid with most markers lost but some retained. The gastric
DNA templates. Additionally, each new STS was tested KatoIII cells appeared to have lost the D3S1481 marker
against the YAC contig (also shown in Figure 1A) against and the telomeric portion of the fragile region, from
cell lines with homozygous deletions and rodent±human AP4/5 toD3S2977 (see Figure 1A). The HKI cells, derived
from a nasopharyngeal carcinoma (NPC), had lost thehybrids retaining portions of chromosome 3 (LaForgia
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Figure 2. Structure of Normal and Aberrant
FHIT cDNAs
(A) The nucleotide and predicted amino acid
sequences of the FHIT gene are shown with
positions of exons indicated by arrowheads
above the sequence and positions of primers
used in nested PCR and RACE reactions indi-
cated by arrows below the sequence.
(B) A schematic presentation of some of the
aberrant transcripts observed in uncultured
tumor tissues of digestive organs is shown.
Only transcripts that showed deletion of cod-
ing sequence in Table 2 are presented. The
top line shows the intact FHIT cDNA map.
The thick and thin bars show the coding and
untranslated regions, respectively. The posi-
tions of splice sites are shown by downward
arrows, according to the nucleotide numbers
shown above in (A). The class I transcripts
lack exon 5, while class II transcripts retain
exon 5 but generally lose exon 8. In the tran-
scripts with asterisks, insertions of various
lengths were observed downstream of exon
4. E1±E10 indicate exons 1±10.
region between D3S1481 and the AP4/5 marker, while gion, a polyadenylation consensus sequence, and a
poly(A) tail.CNE2, another NPC-derived cell line, had discontinuous
deletions that included a region near the t(3;8) and the This cDNA was translated and ORF amino acid se-
quences (Figure 2A) compared with the protein data-region between D3S1481 and D3S2977. HeLa cells also
exhibited discontinuous deletions, with one deleted re- bases. The full-length cDNA probe was then hybridized
to Northern blots carrying mRNA from a spectrum ofgion near the t(3;8) and one between D3S1481 and
AP4/5. The NPC-derived CNE1 cells were tested with tissues. As shown in Figure 3A, the cDNA detected the
ubiquitously expressed 1.1 kb transcript.most markers without detection of a deletion. Thus,
there are many different tumor-associated 3p14.2 chro-
mosome breakpoints surrounding the t(3;8), the FRA3B
Relationship of the cDNA to the Genomiclocus, and the homozygously deleted region covered
Map of the Regionby the cosmid contig.
Oligonucleotide primers from the initially trapped exon
were used to generate intron sequences from cosmid
76; these sequences were used in turn to prepare prim-Isolation of cDNAs
The six cosmids covering the homozygous deletion, ers and probes to map the exon (E5 in Figure 1A) on
the cosmids, YACs, and DNA from cancer cell lines withshown in Figure 1A, were used in exon-trapping experi-
ments aimed at identifying genes within the deleted re- deletions, as illustrated in Figures 1A and 1C. Using
cDNA as template, oligonucleotide primer pairs brack-gion. Sequences of trapped exons were compared
against nucleotide sequence databases, and one exon, eting the exons upstream and downstream of exon 5
were then used to amplify cDNA fragments to serve astrapped from a cosmid 76 subclone (c76, Figure 1A),
matched a number of cDNA sequences from breast probes for mapping the 59 and 39 flanking exons on
the cosmid contig; these probes demonstrated that the(GenBank accession numbers R53187 and R86313) and
fetal liver and spleen (R11128) libraries submitted by the cDNA sequences 59 and 39 of exon 5 were not within
the 648D4 cosmid contig covering the homozygous de-Washington University±Merck expressed sequence tag
(EST) Project. A 23 bp oligonucleotide primer designed letions. Thus, cosmid libraries from YACs 850A6 and
750F1, which extend centromeric and telomeric to thefrom this sequence (primer X8, Figure 2A) was used in
primer extension to obtain a 59 extended product of the fragile region deletions, respectively, as shown in Figure
1A, were prepared and screened with the 59 and 39cDNA by a rapid amplification of cDNA ends (RACE)
reaction. The longest product (370 bp) from the RACE cDNA probes flanking exon 5. Cosmids containing the
remaining exons were then used to derive intron se-reaction detected a ubiquitously expressed 1.1 kb
mRNA by Northern blot analysis of mRNAs from various quences using cDNA primers, and the structure of the
gene was determined as shown in Figure 1A. The cDNAnormal tissues. The size was similar to the length of the
largest cDNA clone isolated from a normal colon cDNA consisted of ten exons that were distributed among
three YAC clones (Figure 1A); exons 1 through 4 mappedlibrary, using the same DNA fragment as a probe. The
DNA sequence analysis of this full-length clone (Figure to YAC clone 850A6, exon 5 was present in all three
YAC clones, and exons 6 through 10 mapped to YAC2A) revealed a 59 untranslated region of more than 350
bp, followed by an initial methionine codon with sur- clone 750F1. Only exon 5 fell within the region of homo-
zygous deletion in tumor-derived cell lines, i.e., withinrounding sequence fitting Kozak's rule, an open reading
frame (ORF) of 147 amino acids, a 39 untranslated re- YAC clone 648D4, as illustrated for some cell lines in
Cell
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Figure 4. Alignment of Amino Acid Sequences of HIT Family Pro-
teins and Translation of FHIT cDNAsFigure 3. Expression of the FHIT Gene in Normal Tissues and
Tumors Alignment was performed using BOXSHADE version 3.0. White type
on a black background indicates two or more identical residues atNorthern blot (A and B) and RT±PCR analysis (C) of normal and
a position; stippling indicates similarity. PAPH1 (accession numbertumor-derived FHIT mRNA.
U32615) designates the S. pombe aph1 gene, and CAPH1 (acces-(A) Normal mRNAs (2 mmg/lane) from spleen (lane 1), thymus (lane
sion number U28374), designates a potential S. cerevisiae aph1.2), prostate (lane 3), testis (lane 4), ovary (lane 5), small intestine
PHIT indicates the HIT family member from the cyanobacterian Sy-(lane 6), colon (mucosal lining) (lane 7), and peripheral blood leuko-
nechococcus Sp. (accession number P32084), BHIT, indicates thecytes (lane 8), hybridized with the FHIT cDNA probe.
protein kinase C inhibitor from Bovine taurus (accession number(B) mRNAs (2 mg/lane) from normal small intestine (lane 1) and
P16436)), MHIT from Mycoplasma hyorhinis (accession numbermRNAs from tumor-derived cell lines: KatoIII (lane 2), HK1 (lane 3),
M37339), YHIT from S. cerevisiae (accession number Q04344); theLoVo (lane 4), CNE2 (lane 5), CNE1 (lane 6), Colo320 (lane 7), LS180
FHIT protein is 69% similar to the S. pombe (PAPH1) gene over a(lane 8), hybridized with the FHIT cDNA probe (top). The same blot
length of 109 amino acids.was hybridized with a b-actin cDNA probe (bottom).
(B) In vitro translation products from recombinant plasmids con-(C) Amplified products observed after nested RT±PCR amplification
taining different alleles of the FHIT gene: pFHIT1 with a deletion ofof mRNAs from matched uncultured tumor (T) and normal (N) tissues
noncoding exon 4 (lane 1); pFHIT2 with an insertion of 72 bp betweenof the same patients (J4, 9625, 5586, E37, E32, and E3), or mRNAs
exons 4 and 5 (lane 2); pFHIT3 with a wild-type FHIT lacking exonfrom tumor tissues only. Arrowheads show the positions of amplified
1 (lane 3); the pFHIT full-length wild-type gene in Bluescript (laneproducts with abnormal DNA sequence. The details of the DNA
4); control reaction, in vitro translation from the pBCAH vector, car-sequences of corresponding transcripts are shown in Table 2 and
rying a portion of the extracellular region of the PTPRG gene (pre-Figure 2B. White dots in the tumor lanes show the position of tran-
dicted molecular weight of 40 kDa) (lane 5).scripts with normal DNA sequence.
the Fragile Histidine Triad gene or the FHIT gene, is
Figure 1C. The coding region of the ORF began in exon shown in Figure 4A compared to the other members of
5 and ended in exon 9, as shown in detail in Figures 2A the HIT family. The highest homology of the FHIT protein
and 2B. (z50% identity) is to the yeast Schizosaccaromyces
Most interestingly, the first three exons (E1, E2, and pombe diadenosine 59,5999-P1, P4 (Ap4A), asymmetrical
E3) of the gene mapped centromeric to the t(3;8) break, hydrolase gene (aph1), shown in Figure 4A as PAPH1
between the t(3;8) break, and the 59 end of the PTPRG (Huang et al., 1995) and a potential aphl gene, CAPH1,
gene, as determined by amplification of these exons from Saccaromyces cerevisiae. The consensus se-
from the YAC DNAs and DNAs derived from hybrids quence for the HIT family proteins is shown below the
carrying portions of chromosome 3, derived from the amino acid sequences in Figure 4A.
t(3;8) break and a FRA3B break, as illustrated in Figure To recapitulate, the FHIT gene, which may be the
1C. Thus, this gene became a strong candidate for human cognate gene for the S. pombe Ap4A hydrolase
involvement in initiation of the familial RCCs, because gene, spans a >500 kb region that includes the t(3;8),
one copy of the gene is disrupted by the translocation. the FRA3B, and a tumor cell±specific commonly deleted
The homology search in amino acid sequence data- region.
bases showed a significant homology to a group of
proteins that have a histidine triad motif, designated Expression of the FHIT Gene
HIT proteins (Seraphin, 1992). The predicted amino acid Our previous study placed the BE758±6 locus, first iden-
tified by RDA (Lisitsyn et al., 1995), and the microsatellitesequence of the cDNA for the human gene, designated
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marker, D3S1300, within the region of common loss in similar). The tumor-derived cell lines exhibited a pattern
of products ranging from one apparently normal-sizeda variety of tumor-derived cell lines, and our loss of
heterozygosity (LOH) study of gastric and colon tumors amplified transcript tonumerous aberrant bands without
a normal-sized band. The sequencing of the aberrantdetected a high frequency of allelic deletion, often in-
volving D3S1300 (Kastury et al., 1996a), in the region bands revealed numerous abnormal products, some of
which are illustrated in Figure 1B. Colon tumor-derivedbetween the t(3;8) and the D3S1234 locus (see Figure
1A). Now, the localization of both the BE758±6 and CCL235 and CCL234 cell lines did not show deletion
of the STS markers tested, but both showed aberrantD3S1300 loci within the FHIT gene locus, close to the
first coding exon, exon 5, suggested that the FHIT gene transcripts, as illustrated, with CCL235 exhibiting a nor-
mal-sized product in addition. HT29 and KatoIII cell lineswas the target of deletion in uncultured tumors, as well
as tumor-derived cell lines. To begin an analysis of FHIT both showed homozygous deletion (Kastury et al.,
1996a), but the KatoIII cell line exhibited a deletion oftranscripts in tumor-derived cells, poly(A)1 mRNAs from
tumor-derived cell lines and normal tissues was studied the telomeric portion of the homozygously deleted re-
gion and not the region containing exons 4 and 5, norby Northern blot analysis.
A low level of expression of the FHIT gene occurred the region of exon 6, exons that are all missing in the
aberrant RT±PCR product, as illustrated in Figure 1B.in all human tissues tested, (as shown in Figure 3A), for
spleen, thymus, prostate, testis, ovary, small intestine, Ten cases of uncultured esophagus, nine of stomach,
and eight of colon tumors were also analyzed, and aber-colon, and peripheral blood lymphocytes. The major
transcript was z1.1 kb with a longer transcript at z5 rant transcripts were observed in five, five, and three
cases, respectively (summarized in Tables 1 and 2 andkb, which was barely detectable on some blots; this
longer transcript may represent an incompletely pro- illustrated in Figures 2B and 3C). The sequence analyses
of the aberrant cDNAs revealed absence of various re-cessed precursor RNA. Similar transcripts were seen in
mRNA from brain, heart, lung, liver, skeletal muscle, gions between exons 4 and 9 (Table 2; Figure 2B), while
the RT±PCR and cDNA sequence analyses of normalkidney, and pancreas.
mRNAs from tumor-derived cell lines with known ho- tissue mRNAs from the same organs did not exhibit
alterations of the coding region sequence (E3, E12, E32,mozygous deletions in the fragile region exhibited vary-
ing levels of FHIT transcripts, from barely detectable E37, J1, J4, J9, 9625, 5586, and 9575). In 8 of 13 cases
with aberrant transcripts, normal-sized transcripts were(KatoIII, HKI, and LoVo mRNA; Figure 3B, lanes 2±4,
respectively) to an almost normal level (LS180, lane 8), also observed (E3, E12, E13, E37, 9625, 9575, J7, and
J9, Figure 3C; E12 and 9575, data not shown), while inrelative to normal small intestine mRNA (lane 1).
Note that the NPC cell lines with (CNE2 and HK1; 5 of 13cases normal-sized transcripts werenot detected
(J3 and J4; Figure 3C), or were barely detected (E32,Figure 3B, lanes 5 and 3) and without (CNE1; Figure 3B,
lane 6) documented homozygous deletions (Kastury et 5586, and J1; Figure 3C). In most of the aberrant tran-
scripts, the beginning and the end of the deleted por-al., 1996a) expressed barely detectable FHIT mRNA. The
NPC-derived cell line CNE2 exhibited a possible smaller tions of the transcripts coincided with splice sites (Fig-
ure 2B), suggesting that the cDNA deletions resultedtranscript (Figure 3B, lane 5), while Colo320, a colorectal
carcinoma±derived cell line without a deletion, exhibited from the loss of genomic regions containing or sur-
rounding the relevant lost FHIT exons. The aberrant tran-an apparently normal-sized FHIT transcript (Figure 3B,
lane 7), although it should be noted that size alone does scripts can be classified into two groups (class I and II,
Figure 2B): class I transcripts lack exon 5, which hasnot imply presence of a wild-type transcript. One conclu-
sion of the Northern blot analysis is that there was no the initial methionine codon of the FHIT ORF, resulting
in the loss of the intact ORF; class II transcripts havedirect relationship between size or abundance of tran-
script and detection of homozygous deletions in specific an intact initial methionine codon but do not include
exon 8, except for 9575b, which exhibited a frameshifttumor-derived cell lines, suggesting that there may be
small deletions in some tumor cell lines that have not after exon 6. Thus, in all the class II transcripts, the
wild-type ORF of exon 8, the histidine triad-containingbeen detected with the available markers.
domain, is not present. Moreover, some of the class II
transcripts exhibited loss only of exon 8 (E3a, E12a,
Reverse Transcription±Polymerase Chain 9625a, 9575a, and J9a; Figure 2B), suggesting that exon
Reaction and cDNA Sequence Analysis 8 was the target of deletion. Since exon 8 encodes the
of Tumor-Derived mRNA histidine triad motif, it is likely that neither class I nor
To look for abnormalities in FHIT transcripts from de- class II transcripts, constituting the major fraction of
leted and nondeleted tumor cell lines, we reverse-tran- aberrant transcripts, can encode a fully functional pro-
scribed mRNAs with (dT)17 primer, amplified the cDNA tein. However, there is an in-frame methionine codon in
with 59 and 39 primers, and then reamplified using prim- exon 6 (see Figure 2B), and in some cases, insertions
ers inside the original primers (nested PCR), as de- contribute an in-frame Methione (data not shown); thus,
scribed in Experimental Procedures. Positions of the the majority of aberrant transcripts could encode partial
primers are shown in Figure 2A. The amplified products proteins, with or without the HIT domain, as indicated
were separated on agarose gels, and fragments were in Table 2. Insertions of various lengths of DNA not
cut from the gels and sequenced (examples of aberrant derived from the FHIT gene were observed in some
bands are shown for mRNAs of uncultured tumors in transcripts, but only downstream of exon 4 (5586a,
Figure 3C; reverse transcription±polymerase chain reac- 5586b, 9625, J3, and J4; Table 2). A minor group of
aberrant transcripts retained intact full-length ORFs, buttion (RT±PCR) products from tumor cell lines were very
Cell
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Table 1. Derivation of FHIT RT±PCR-Amplified Products and cDNA Sequences from Uncultured Tumors of Gastric Organs
Cases with Aberrant Transcripts
Number of
Origin of Tumors Cases Analyzed Number of Cases Codes1
Esophagus 10 5 E3*, E12*, E13
E32*, E37*
Stomach 9 5 J1*, J3, J4*, J7, J9*
Colon 8 3 9625*, 5586*, 9575*
1 In cases with asterisks, normal tissues from the same organs were analyzed and did not exhibit alterations in the coding region sequences.
were missing exon 4 (J1a; Table 2), or had insertion The FHIT Protein
The protein sequence predicted by the FHIT cDNA isof 72 bp of DNA sequence in the 59 noncoding region
between exon 4 and 5 (E37a, Table 2; Figure 1B). very similar (57 of 109 amino acid identities; 76 of 109
or 69%, similarities, calculated by the National CenterTo determine whether the wild-type FHIT cDNA and
various cDNAs derived from tumor-specific transcripts, for Biotechnology Information (NCBI) BLAST server) to
the S. pombe aph1 gene (Huang et al., 1995), as shownwhich retained the entire coding region, could be trans-
lated in vitro, several recombinant plasmids were con- in the amino acid alignment in Figure 4A, where PAPH1
represents the S. pombe sequence.structed, each containing a FHIT gene downstream from
the T7 promoter and lacking the first noncoding exon. The S.pombe aph1 enzyme was cloned by purification
of the enzyme, amino acid sequencing of the N-termi-The pFHIT1 plasmid carried a cDNA missing exon 4
from the CCL234 colon cancer cell line. Plasmid pFHIT2 nus, and design of primers to amplify a partial cDNA;
the full-length genomic region and a cDNA of 1.2 kbcarried a cDNA from esophageal tumor E37 with an
insertion of 72 bp between exons 4 and 5. The pFHIT3 were then cloned, sequenced, and translated (Huang et
al., 1995). By similar methods, a human Ap4A hydrolaseplasmid contained the wild-type FHIT gene. The con-
structs were used for in vitro translation and analysis (APH1) has been cloned, sequenced, and translated
(Thorne et al., 1995) and, surprisingly, does not resembleof translation products (Figure 4B), which showed the
predicted 16.8 kDa protein translated from each cDNA the S. pombe aph1 gene nor the FHIT gene. Since higher
eukaryotes appear to possess a single 16±21 kDa Ap4Aconstruct.
Table 2. Aberrant Transcripts Observed in Uncultured Tumors
Insertion3
Tumor-Derived Deletion Size Putative Protein4
Transcript1 (position2) (bp) Homology Effect Coded in Frame
*E3 a 280±348 72 NS Ex 8 loss HIT(2)
*E12 a 280±348 Ð Ð Ex 8 loss HIT(2)
b 122±516 Ð Ð FS after Ex 6 HIT(2)
*E13 a 217 to 249 Ð Ð Ex 5 and 6 loss Ð
b 217 to 348 Ð Ð Ex 5±8 loss Ð
E32 Ð 280±449 Ð Ð Ex 8 and 9 loss HIT(2)
*E37 a Ð 72 NS None intact
b 273 to 173 Ð Ð Ex 5 loss HIT(1)
*9625 a 280±348 Ð Ð Ex 8 loss HIT(2)
b 217 to 279 87 Alu Ex 5±7 loss Ð
c 2110 to 204 Ð Ð Ex 4 and 5 loss HIT(1)
*5586 a 217 to 349 135 Alu Ex 5±8 loss Ð
b 217 to 279 37 NS Ex 5±7 loss Ð
*9575 a 280±348 Ð Ð Ex 8 loss HIT(2)
b 60±181 Ð Ð FS after Ex 5 HIT(2)
c 2110 to 348 Ð Ð Ex 4±8 loss Ð
J1 a 2110 to 217 Ð Ð None Intact
b 217 to 279 Ð Ð Ex 5±7 loss Ð
J3 Ð 217 to 279 173 Alu Ex 5±7 loss HIT(1)
J4 Ð 217 to 457 305 Alu Ex 5±9 loss Ð
*J7 a 2110 to 249 Ð Ð Ex 4±6 loss Ð
*J9 a 280±348 Ð Ð Ex 8 loss HIT(2)
All the aberrant transcripts that involve the coding sequence of the FHIT gene are shown in Figure 3B.
1 In tumors with asterisks, normal transcripts without alteration of coding region sequence were also observed.
2 The positions of the first and last nucleotides of the deletions are shown according to the nucleotide numbers in Figure 2.
3 The position of all insertions was downstream of exon 4.
4 Putative protein coded in frame with the FHIT protein is shown: HIT(1), protein with HIT motif; HIT(2), protein without HIT motif; 2, no protein
in frame.
Abbreviations: Alu, Alu repeat; FS, frameshift; NS, no significant homology; Ex, exon.
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Figure 5. Organization of the FHIT Gene Rel-
ative to Documented Chromosome Breaks in
the 3p14.2 Fragile Region
One FHIT allele is disrupted in all the translo-
cation carriers of the t(3;8) family, with exons
1, 2, and 3 remaining on the derivative 3 chro-
mosome and exons 4±10, including the entire
coding region, being translocated to the de-
rivative 8 chromosome, as illustrated above.
The hybrid cell line cl3 with a de novo FRA3B
break just telomeric to exon 5 has lost most
of the FHIT coding region. The KatoIII cells
apparently retain all FHIT exons, but encode
only an abnormal transcript that lacks exons
4±7 and thus cannot produce FHIT protein.
The MB436 and HT29 cells have both lost
exon 5 through deletion of different segments
of the fragile region.
asymmetrical pyrophosphohydrolase (cited in Thorne et cell lines exhibit apparent discontinuous homozygous
deletions. Figure 5 diagrams the relationship betweenal., 1995), it is thus not clear if the FHIT gene is a human
APH1 enzyme, although it may be a human cognate of the various types of chromosome breaks in 3p14.2 and
the organization of the FHIT gene relative to the breaks.the S. pombe aph1 enzyme.
The FHIT gene is also very similar to a S. cerevisiae Note that in Figure 5, the chromosome breaks and dele-
tions in the KatoIII gastric carcinoma-derived cells leavegene (CAPH1 in Figure 4A) that may be a cerevisiae
aph1 gene, based upon the homology to PAPH1 shown the coding region intact, but we have observed only an
aberrant FHIT transcript in this cell line. Thus, inapparentin Figure 4A. The other proteins in Figure 4A are mem-
bers of this HIT gene family, a family of proteins present chromosomal abnormalities must account for the lack
of normal transcription in KatoIII and other tumor cells.in prokaryotes, yeast, and mammals, described by Ser-
aphin (1992). The signature feature of the family is the Some cancer-derived cell lines and uncultured tumors
showed transcripts with alterations to noncoding re-histidine triad (Figure 4A; amino acids 94±98 of the FHIT
protein), which for the case of BHIT (Figure 4A), the gions of the FHIT transcript. These transcripts were
translated into full length protein in vitro (Figure 4B), butbovine inhibitor of protein kinase C (PKCI1), has been
shown to be a zinc-binding site (Pearson et al., 1990; perhaps in the tumor cells from which they were derived,
the lack of exon 4, or insertion of new sequences, wouldMozier et al., 1991). The FHIT protein product is only
39% similar to the bovine PKCI1 protein over FHIT amino affect expression of the FHIT protein. Another puzzle,
if the FHIT gene acts as a classical suppressor geneacids 12±100, as calculated by NCBI BLAST. Thus, the
FHIT gene is not likely to be the human PKCI1 gene. with inactivation of both alleles, is the presence of nor-
mal-sized transcripts along with aberrant products inFunctions of the other HIT genes are not known.
the RT±PCR amplification products of tumor-derived
cell lines such as CCL235 (colon), A549 (lung), and HeLaDiscussion
(cervical). It is possible that the aberrant transcripts,
which in most cases might encode partial FHIT proteins,The meaning of fragile sites for cancer has been a sub-
ject of speculation for years, and the near coincidence could interferewith the function of a normal FHITprotein.
A number of the uncultured tumors also exhibited aber-of the chromosomal position of the FRA3B and the t(3;8)
translocation at 3p14.2 has been especially intriguing. rant and normal-sized products, and sequencing
showed that some of these normal-sized products wereThe FRA3B is constitutive; that is, after treatment of
peripheral blood lymphocytes with z0.4 mM aphidicolin, indeed wild-type products. In these cases, the normal
transcripts could have derived from admixed normalwhich interferes with the action of DNA polymerase a,
the characteristic gaps in chromosome region 3p14.2 cells. We have not yet observed point mutations within
the coding region of any FHIT transcripts, perhaps sug-are observed in z70% of metaphases from all individu-
als. So the structural basis for the induction of gaps is gesting that aberrant FHIT genes usually are the result
of deletions.present in all individuals. It is also known that within
the 3p14.2 band, some of the induced gaps represent Aphidicolin, which inhibits the action of DNA polymer-
ase a, induces the gaps and breaks observed in thechromosome breaks, which occur possibly at several
sites in the chromatin of an z200±300 kb region (Par- FRA3B region in normal metaphases; thus, in the diges-
tive tract tumors and tumor cell lines we have studied,adee et al., 1995). Thus, the sequences involved in gaps
and breaks may occur in more than one site within the the genomic deletions resulting in aberrant transcription
and loss of functional FHIT protein could have beenfragile region. Perhaps the FRA3B appears to be the
most common fragile site because it actually represents induced by exposure of these organs to other agents
that interfere with DNA replication, such as nicotine,a collection of different fragile sites in a small chromo-
somal region. The specific sequences responsible for caffeine, alcohol, or other known carcinogens. Interest-
ingly, zinc deficiency is associated with a high frequencythe breaks at FRA3B in hybrid cells have not been de-
scribed, but we have observed that many tumor-derived of esophageal tumors in human (Yang, 1980) and rat
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(Fong et al., 1978); zinc deficiency may cause prolifera- from sporadic tumors, and have observed normal-sized
products, which have not yet been cloned and se-tion of the epithelial cells lining the esophagus (Yang et
quenced. Nor have we yet observed homozygous dele-al., 1987), so perhaps zinc deficiency mimics loss of
tions in RCCs using a subset of STS markers in thethe FHIT protein, which may require bound zinc for its
fragile region. Nevertheless, it would be surprising if thefunction. It is, therefore, interesting that FHIT gene exon
FHIT gene is not involved in some sporadic RCCs.8, carrying the HIT motif, the presumptive zinc-binding
Since the FHIT gene is probably ubiquitously ex-site, is a target of deletion in numerous digestive tract
pressed, it may not be surprising if it can serve as atumors.
tumor suppressor gene for specific tissues of many dif-Whether this region of 3p14.2 contains repeated CCG
ferent organs, perhaps predominantly of the digestiveor CGG triplets is not yet known, but because there are
tract, or maybe predominantly organs with epithelial celldifferences between the rare, inherited folate-sensitive
linings. Another common denominator of the types offragile sites that have been characterized and the com-
tumor exhibiting aberrant FHIT alleles might be that theymon, constitutive, aphidicolin fragile sites, perhaps a
are predominantly organs directly exposed to environ-different basis for the fragility should be expected. Thus
mental carcinogens; some of the types of tumors exhib-far, we have noted that there are many Alu repeats in
iting FHIT gene aberrations occur very frequently in re-the telomeric portion of the fragile region, and there is
stricted regions of the globe, NPC in China, gastrica (TAA)15 repeat in this same commonly deleted region,
cancer in southeast Asia, and often there are environ-for which the number of repeats is highly variable (Kas-
mental factors at play. A possible role for Epstein-Barrtury et al., 1996a). Also in z9 kb pairs of sequenced
virus (EBV) in promotion of Chinese NPCs might beportions of the cosmid S8 (telomeric portion of the fragile
through viral DNA integration into the FRA3B region,region, see Figure 1A), several Alu repeats and a long
suggested by the previous experiments of Rassool etinterspersed repetitive element (LINE) were encoun-
al. (1992), showing apparent preferential integration oftered; the nucleotide content of the sequenced region
exogenous DNA into induced fragile sites in culturedwas 57.4% A and T residues, while the FHIT cDNA nucle-
cells. Similarly, human papillomaviruses associated with
otide content was 48% A and T. A high A and T content
cervical carcinomas might promote induction of the
is characteristic of some origins of DNA replication, es-
FRA3B, contributing to the loss of heterozygosity on 3p
pecially in yeast, and in fact it has been speculated that
in cervical cancers (Yokota et al., 1989) and possibly to
Alu repeats may be connected with replication in higher inactivation of the FHIT gene.
eukaryotes. Another notable feature of the FHIT gene is The observation of strong similarity of the FHIT gene
that nearly all the exons end with the sequence AG, the to S. pombe Ap4A hydrolase does not supply obvioususual sequence for splice acceptor sites. Based on our clues to the in vivo function of the FHIT protein, nor to
observation of frequent aberrant splicing in this fragile the mechanism of its function as a candidate tumor
region, it is tempting to speculate that the region is suppressor gene. Specific roles for the diadenosine
especially rich in sequences resembling splice acceptor Ap4A have not been defined (Huang et al., 1995), and it
sites. is not clear that the Ap4A hydrolase activity is the only,
Studies of FHIT gene RT±PCR products from RNA of or even the major, in vivo function of these proteins.
numerous cell lines suggested that FHIT gene abnormal- Very little is known of the function of the other members
ities could be important not only in airway and digestive of the HIT family. If indeed the FHIT gene is the cognate
tract tumors such as nasopharyngeal, esophageal, of the S. pombeaph1 gene, then the strong conservation
stomach, and colorectal carcinomas, but possibly also (69% similarity) between the yeast and human genes
in ovarian, cervical, and lung tumors, osteosarcoma, suggests important functions. Whether the FHIT gene
and some leukemias; also a bladder and breast carci- does or does not encode an Ap4A hydrolase, it is likely
noma cell line exhibited homozygous deletions in the that the study of S. pombe aph1 knockouts and other
fragile region (Lisitsyn et al., 1995; Kastury et al., 1996a). S.pombe aph1 mutations will be useful in understanding
Thus, uncultured tumors of these types should be tested the functions of the FHIT protein.
for FHIT gene abnormalities. There is some suggestion that as an intracellular regu-
latory molecule, Ap4A may regulate ability of cells toClear cell RCCs might also be expected to involve
adapt to metabolic stress such as heat, oxidation, andFHIT gene aberrations because the FHIT gene is dis-
DNA damage; thus, deviation from a normal level ofrupted by the familial RCC translocation break in 3p14.2
Ap4A may result in the inability of cells to adapt to envi-and the translocation/FRA3B region is the target of al-
ronmental stresses imposed by carcinogens or viruseslelic loss in most sporadic clear cell RCCs (Druck et
that cause genetic damage.al., 1995). Since the FHIT ORF is contained in exons 5
through 9, translocated to chromosome 8 in the t(3;8)
Experimental Proceduresfamily, it is possible that both alleles could still be ex-
pressed in someor all tissues. If theFHIT gene disruption
Tissues and Cell Lines
is the first ªhitº to a suppressor gene in this family, then Matched normal and cancerous tissues from patients with primary
the second FHIT allele should be altered in the t(3;8) esophageal, colon, and stomach carcinomas were obtained imme-
diately after surgery, and tumors were dissected to eliminate normaltumors. Since we have not yet detected point mutations
tissue before preparation of DNA. Many cell lines were obtainedin the FHIT gene, the best way to look for alterations of
from the ATCC. The RC kidney cell lines wereprovided by E. Lattime.the FHIT gene in t(3;8) RCCs would be to amplify the
FHIT reverse transcript, as done for uncultured tumors RNA Extraction and Reverse Transcription
in this study. We have done this experiment for RNA Total and poly(A)1 mRNA was extracted from cell lines and tissues
using the RNAzol kit (TelTest, Incorporated) or the FastTrack Kitfrom two RCC cell lines and two uncultured RCCs, all
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(Invitrogen), respectively. To obtain mRNA from tissues, fresh speci- cut out and subcloned into the pSPL vector and transfected into
COS7 cells, according to the instructions of the manufacturer. Themens were frozen immediately after excision and stored at 2858C
or in liquid nitrogen until extraction of mRNA. RNA was stored as DNA inserts trapped between the splice sites of the vector were
sequenced by a primer supplied with the vector (GIBCO/BRL). Thea pellet under ethanol or solubilized in RNase-free water and kept
at 2708C. Reverse transcription was performed in 30 ml final volume cDNA was extended in the 59 direction by PCR amplification of a
total human fetal brain cDNA using an exon-specific primer, X8, andof 50 mM Tris±HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM DTT,
2 mM dNTPs, 500 ng oligo(dT), 600 units of MMLV-RT (Gibco-BRL), a RACE reaction kit (Clontech). The normal colon cDNA library was
purchased from Clontech.40 Units RNasin (Promega), and 2 mg of RNA. This reaction was
incubated at 378C for 90 min and boiled for 5 min.
FHIT Exon MappingDNA Sequence Analysis
The genomic sequences of exon-intron junctions of the FHIT genecDNA, genomic clones, and putative exons were sequenced using
were determined by sequencing the positive cosmids with primersprimers specific for vector-flanking sequences and various synthetic
derived from the cDNA. Localization of exons of the FHIT gene wasoligonucleotides. RT±PCR products were directly sequenced after
determined by PCR amplification using primers derived from eachisolation of bands from low melt agarose and purification by column
exon, with YAC and chromosome 3 hybrid DNAs as templates. Thechromatography (QIAGEN). Sequencing of double-stranded plas-
primer sequences used to obtain cDNA probes flanking exon 5 were:mids, PCR products, and phage or cosmid genomic clones was
59-TCTGCTCTGTCCGGTCACA-39 (nucleotides 2355 to 2337) withperformed using Taq DyeDeoxy Terminator Cycle Sequencing Kits,
primer X8 (shown in Figure 2A) for 59 flanking exons; 59-ATGTCCTTGApplied Biosystems, Incorporated; reaction products were electro-
TGTGCCCGCT-39 (nucleotides 105 to 123) with 3D2 (see Figure 2A)phoresed and recorded on the 373 or 377 DNA sequencer, Applied
for 39 flanking exons.Biosystems, Incorporated. Sequences were analyzed using GCG,
BLAST, and GRAIL software.
Northern Blot and HybridizationPCR Amplification
We electrophoresed 2 mg of mRNAs through a 1.5% agarose gel inThe oligonucleotides for generating probes, PCR products, and RT±
2.2 M formaldehyde and 13 MOPS buffer and blotted to a positivelyPCR products were designed using the computer program Oligo
charged membrane by standard procedures. Northern blot filters of4.0 (National Biosciences). Hybridization probes were produced by
multiple normal tissue mRNAs were purchased (Clontech). The FHITPCR amplication using various FHIT-specific primers, as indicated
cDNA probe for hybridization was obtained using the FHIT cDNAin Results. Sequences and positions of some primers are shown in
as template for PCR amplification with the following primer pair:Figure 2A.
59-TGAGGACATGTCGTTCAGATTTGG-39, nucleotides 27 to 17;PCR reactions were carried out in 12.5 or 25 ml final volume with
59-CTGTGTCACTGAAAGTAGACC-39, nucleotides 449 to 429.1±100 ng of template, 20±40 ng of primers, 10 mM tris±HCl (pH 8.3),
Probes were labeled by random priming with [32P]dCTP, and 23 10650 mM KCl, 0.1 mg/ml gelatin, 15 mM MgCl2, 200±600 mM dNTPs, cpm/ml was hybridized to each filter using standard methods.and 0.5±2.5 Units of Taq polymerase, Applied Biosystems, Incorpo-
rated. The amplifications were performed in a Perkin±Elmer Cetus
thermal cycler for 30 cycles of 948C for 30 s (for denaturation), Nested RT±PCR and Sequencing of cDNAs
608C (varied for specific primer pairs) for 30 s (for annealing), and First strand cDNAs were synthesized, and 1 ml of each product was
extending at 728C for 30±45s. The PCR products were visualized in subjected to a first round of PCR amplification with 30 cycles of
ethidium bromide±stained low melting agarose gels. 958C for 20 s, 608C for 30 s, and 728C for 1 min, with 5% dimethylsulf-
oxide and 0.5 mM spermidine in 10 ml reaction volume under stan-
Identification of YACs dard conditions, using primers 5U2 and 3D2, indicated in Figure 2A.
We and others (Boldog et al., 1993, 1994; Wilke et al., 1994; Michaelis We subjected 1 ml of the reaction products, after 20-fold dilution,
et al., 1995; Kastury et al., 1996b) hadpreviously identified the 850A6 to a second round of PCR amplification using nested primers 5U1
clone from the Genethon mega YAC library as containing the and 3D1 (shown in Figure 2A), under the conditions noted above,
D3S1300 and D3S1481 markers (Roche et al., 1994). Overlapping except the reaction volume was 30 ml. The PCR products were run
YACs were identified by analysis of the GenBank database infor- on 1.5% agarose gels, stained with ethidium bromide, and purified,
mation. and 2.5 ng was sequenced using the 5U1 primer.
Identification of Region-Specific STSs
The A6URA marker was from the 850A6 URA end, and A3 from an In Vitro Transcription and Translation
Aluvectorette±amplified fragment of 850A6 (Kastury et al., 1996b); Three different fragments of DNA containing the FHIT gene were
BE758-6, and D3S1480-amplified fragments were used as probes obtained by PCR, using oligonucleotides UR5 (59-CTGTAAAGGTCC
to select phage genomic clones from which end sequences were GTAGTG-39, nucleotides 2171 to 2154 in Figure 2A) and O6
obtained and sequence tagged. A phagegenomic clone for D3S1300 (59CTGTGTCACTGAAAGTAGACC39, the reverse complement of nu-
was selected from the 850A6 (Kastury et al., 1996b) phage library, cleotides 429-449). Amplifications were performed in 100 ml final
and end clone D3S1300E3 was isolated. Other D3S and WI marker volume of 10 mM Tris±HCI (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 200
primer pairs were obtained from Research Genetics or were synthe- mM deoxynucleotide triphosphates, 10 ng of RT±PCR products, and
sized from sequences provided in the WI database. The (TAA)15 2.5 U of Taq polymerase using an Omni Gene Thermal Cycler for
trinucleotide repeat, designated locus ph13, and the AP4/5 STS 25 cycles, consisting of 948C for 1 min, 528C for 1 min, and an
were previously described (Kastury et al., 1996a). extension step at 728C for 45 s. PCR products were inserted in a
PCRII plasmid using the TA cloning system (Invitrogen). Recombi-
Cosmid Mapping nant vectors, containing the normal FHIT and aberrant genes under
High molecular weight YAC containing yeast DNA in agarose plugs the control of the T7 promoter, were sequenced and used for in
was partially restricted with the Sau3AI enzyme and subcloned into vitro transcription and translation.
a cosmid vector as described (Ohta et al., 1995). This cosmid library The in vitro transcription and translation reactions were performed
was initially screened with DNA probes derived from STSs previously by TnT-coupled reticulocyte systems (Promega) in a final volume
mapped to this region. The ends of the insert DNAs flanking the of 50 ml containing 1/2 vol of rabbit reticulocyte lysate, 1 mg of
cosmid vector were sequenced to find new STSs, which were used recombinant plasmid DNA, 10 U of T7 polymerase, 20 mM amino acid
as probes to rescreen the cosmid libraries. mixture without methionine, 40 mM [35S] methionine (Amersham), and
40 U of RNasin ribonuclease inhibitor. Reactions were carried out
for 90 min at 308. The synthesized proteins were analyzed by SDS±Exon Trapping and cDNA Cloning
The cosmid DNAs were partially restricted with Sau3AI enzyme and polyacrylamide gel electrophoresis (SDS±PAGE) and autoradiog-
raphy.run on a 1.0% agarose gel, and fragments larger than 2 kb were
Cell
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